Page last updated: 2024-08-22

6-nitroindazole and Prostatic Neoplasms

6-nitroindazole has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Shen, D; Wang, L; Wang, X; Wei, S	1

Other Studies

1 other study(ies) available for 6-nitroindazole and Prostatic Neoplasms

Article	Year
The Effects of (11R)-13-(6-Nitroindazole)-11,13-Dihydroludartin on Human Prostate Carcinoma Cells and Mouse Tumor Xenografts. Medical science monitor : international medical journal of experimental and clinical research, 2020, Feb-09, Volume: 26 Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Humans; Indazoles; Male; Mice; Prostatic Neoplasms; Reactive Oxygen Species; Santonin; Xenograft Model Antitumor Assays	2020

Article

Year

The Effects of (11R)-13-(6-Nitroindazole)-11,13-Dihydroludartin on Human Prostate Carcinoma Cells and Mouse Tumor Xenografts.

Medical science monitor : international medical journal of experimental and clinical research, 2020, Feb-09, Volume: 26

Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Humans; Indazoles; Male; Mice; Prostatic Neoplasms; Reactive Oxygen Species; Santonin; Xenograft Model Antitumor Assays

2020